FRA
Front Row Advisors’s Medpace MEDP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.96M | Buy |
9,441
+35
| +0.4% | +$11K | 1.03% | 22 |
|
|
2025
Q1 | $2.87M | Sell |
9,406
-3
| -0% | -$914 | 1.1% | 23 |
|
|
2024
Q4 | $3.13M | Buy |
9,409
+9
| +0.1% | +$2.99K | 1.08% | 24 |
|
|
2024
Q3 | $3.14M | Buy |
9,400
+114
| +1% | +$38.1K | 1.12% | 23 |
|
|
2024
Q2 | $3.82M | Sell |
9,286
-1,650
| -15% | -$680K | 1.33% | 15 |
|
|
2024
Q1 | $4.42M | Sell |
10,936
-5
| -0% | -$2.02K | 1.64% | 11 |
|
|
2023
Q4 | $3.35M | Buy |
10,941
+20
| +0.2% | +$6.13K | 1.54% | 14 |
|
|
2023
Q3 | $2.64M | Buy |
10,921
+55
| +0.5% | +$13.3K | 1.22% | 19 |
|
|
2023
Q2 | $2.61M | Sell |
10,866
-304
| -3% | -$73K | 1.16% | 22 |
|
|
2023
Q1 | $2.1M | Buy |
11,170
+15
| +0.1% | +$2.82K | 1.01% | 25 |
|
|
2022
Q4 | $2.37M | Sell |
11,155
-684
| -6% | -$145K | 1.22% | 22 |
|
|
2022
Q3 | $1.86M | Buy |
11,839
+60
| +0.5% | +$9.43K | 0.96% | 29 |
|
|
2022
Q2 | $1.76M | Sell |
11,779
-15
| -0.1% | -$2.25K | 0.87% | 36 |
|
|
2022
Q1 | $1.93M | Buy |
11,794
+985
| +9% | +$161K | 0.78% | 40 |
|
|
2021
Q4 | $2.35M | Buy |
10,809
+409
| +4% | +$89K | 0.88% | 34 |
|
|
2021
Q3 | $1.97M | Buy |
10,400
+150
| +1% | +$28.4K | 0.83% | 39 |
|
|
2021
Q2 | $1.81M | Buy |
10,250
+710
| +7% | +$125K | 0.74% | 46 |
|
|
2021
Q1 | $1.57M | Buy |
9,540
+555
| +6% | +$91K | 0.76% | 45 |
|
|
2020
Q4 | $1.25M | Sell |
8,985
-60
| -0.7% | -$8.35K | 0.64% | 52 |
|
|
2020
Q3 | $1.12M | Buy |
9,045
+65
| +0.7% | +$8.07K | 0.59% | 52 |
|
|
2020
Q2 | $835K | Sell |
8,980
-55
| -0.6% | -$5.11K | 0.52% | 55 |
|
|
2020
Q1 | $722K | Buy |
+9,035
| New | +$722K | 0.49% | 58 |
|